Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-27

Clinical Trial Update: Study to Examine the Effect of the Diuretic Furosemide on the Plasma Levels of Toxins and the Removal of Toxins from the Blood in Patients with Chronic Kidney Disease

View source ↗

Summary

A clinical trial to assess how the diuretic furosemide affects plasma toxin levels and their clearance in patients with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FUROSEMIDE (Furosemide)

Snippet

Sponsor: UMC Utrecht | Conditions: Chronic Kidney Diseases, Renal Failure Chronic | Status: RECRUITING